Clinical Trial Update: Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls [NA]

View source ↗

Summary

Clinical trial update studying plasma oxytocin changes in response to low-dose MDMA versus placebo in patients with central diabetes insipidus and healthy contr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Central Diabetes Insipidus | NA | Status: RECRUITING